Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.709
+0.089 (14.29%)
At close: Jun 26, 2026, 4:00 PM EDT
0.745
+0.036 (5.14%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Humacyte Employees
Humacyte had 184 employees as of December 31, 2025. The number of employees decreased by 36 or -16.36% compared to the previous year.
Employees
184
Change (1Y)
-36
Growth (1Y)
-16.36%
Revenue / Employee
$10,957
Profits / Employee
-$517,484
Market Cap
157.32M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 184 | -36 | -16.36% |
| Dec 31, 2024 | 220 | 35 | 18.92% |
| Dec 31, 2023 | 185 | 21 | 12.80% |
| Dec 31, 2022 | 164 | 18 | 12.33% |
| Dec 31, 2021 | 146 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ADC Therapeutics | 193 |
| Molecular Partners AG | 134 |
| Alpha Cognition | 71 |
| Connect Biopharma Holdings | 64 |
| Pyxis Oncology | 56 |
| Enlivex | 34 |
| Jyong Biotech | 27 |
| Genelux | 26 |
HUMA News
- 10 days ago - Humacyte price target lowered to $1.25 from $1.50 at TD Cowen - TheFly
- 10 days ago - Humacyte Slides: Corporate presentation - Filings
- 11 days ago - Humacyte Transcript: Study result - Transcripts
- 11 days ago - Humacyte Press release: Study result - Filings
- 12 days ago - Humacyte's Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual Meeting - GlobeNewsWire
- 16 days ago - Humacyte price target raised to $4 from $3 at H.C. Wainwright - TheFly
- 16 days ago - Humacyte 47.62M share Spot Secondary priced at $1.05 - TheFly
- 16 days ago - Humacyte, Inc. Announces Pricing of Public Offering of Common Stock - GlobeNewsWire